Personal profile


Dr Laura Porter is an early career research fellow at Monash University in the Monash Biomedicine Discovery Institute. Dr Porter has 9 years experience in prostate cancer research, with a strong translational approach that is applicable to urology and oncology clinical practice. Her expertise involves developing and applying clinically relevant models to study prostate cancer, focusing on tumour pathology and preclinical therapeutic testing. She is currently funded by a Cancer Council Victoria Postdoctoral Fellowship, an NHMRC Ideas Grant, a Cancer Council Victoria Grant-in-Aid and a Prostate Cancer Foundation of Australia Award. 

Dr Porter is involved in establishing patient-derived models within the Melbourne Urological Research Alliance (MURAL), one of Australia’s largest patient-derived xenograft (PDX) collections that is highly sought after by academia and industry partners. PDXs are experimental models created by tumour tissue engraftment. These models accurately represent the biology and heterogeneity of different prostate tumours and recapitulate the tumour microenvironment, thus increasing the likelihood of observing clinically relevant research outcomes. 

Dr Porter's research has led to a Phase I clinical trial for a novel drug combination therapy, and has contributed to a change in international clinical guidelines for the assessment of prostate cancer subpathologies. Her current work is focused on optimising immunotherapy and radioligand therapy for the treatment of prostate cancer. 


Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or